Citation Impact
Citing Papers
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
2007 Standout
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
2015
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
2009 StandoutScience
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Clonality of cell populations in refractory anaemia using combined approach of gene loss and X‐linked restriction fragment length polymorphism‐methylation analyses
1991
CD44: From adhesion molecules to signalling regulators
2003 Standout
Animal models of human disease: zebrafish swim into view
2007 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Are myelodysplastic syndromes “cancer”?
2006
Leukemia and the disruption of normal hematopoiesis
1991
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
2000 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Characterization of human bone marrow‐derived closed circular DNA clones
1993
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
1994 Standout
Stability of K-ras mutations throughout the natural history of human colorectal cancer
1992
Why does the Ras switch “break” by oncogenic mutations?
2004 StandoutNobel
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study
1990
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
ERM proteins and merlin: integrators at the cell cortex
2002 Standout
Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome
1995
N‐ and KRAS mutations in primary testicular germ cell tumors: Incidence and possible biological implications
1995
Molecular mechanisms of cisplatin resistance
2011 Standout
Cancer genes and the pathways they control
2004 Standout
All ras proteins are polyisoprenylated but only some are palmitoylated
1989 Standout
The Hippo Signaling Pathway in Development and Cancer
2010 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Chromosomes, genes, and development of testicular germ cell tumors
2004
Clonal lymphocytes are detectable in only some cases of MDS
1992
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
2001
Assignment<sup>1</sup> of <i>Erbb2</i> to rat chromosome band 10q32.1 by in situ hybridization
1998
Targeting RAS signalling pathways in cancer therapy
2003 Standout
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
1992 Standout
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
2007 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia
1991
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
X‐chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post‐chemotherapy females
1991
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells
2008 StandoutNobel
The ras gene family and human carcinogenesis
1988
Stem cell origins of leukaemia and curability
1993
Urothelial lesions in Chinese-herb nephropathy
1999
Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?
2005
Herbal bioactivation: The good, the bad and the ugly
2003
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
2004
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
1988 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Ethylnitrosourea Induces Neoplasia in Zebrafish (Danio rerio)
2000
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Biological effects of essential oils – A review
2007 Standout
Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes
1992
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion
1993
Mutations of the p53 gene do not occur in testis cancer.
1993
Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation
1992 StandoutNobel
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Mutations and Expression of the ras Family Genes in Leukemias
1996
The BCR-ABL Oncogene Transforms Rat-1 Cells and Cooperates with v-myc
1989
Deficiencies in Mouse Myh and Ogg1 Result in Tumor Predisposition and G to T Mutations in Codon 12 of the K-Ras Oncogene in Lung Tumors
2004 StandoutNobel
The Yeast TFB1 and SSL1 Genes, Which Encode Subunits of Transcription Factor IIH, Are Required for Nucleotide Excision Repair and RNA Polymerase II Transcription
1995 StandoutNobel
Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms
1990
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome
1992
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation
2017 StandoutNobel
A Comprehensive Survey of Ras Mutations in Cancer
2012 Standout
Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene
1992
UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement.
1994
Production of high-titer helper-free retroviruses by transient transfection.
1993 StandoutNobel
Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
2005
Growth Factors and Cancer
1991 StandoutScience
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Differential formation and repair of the mutagenic DNA alkylation product O6-ethylguanine in transcribed and nontranscribed genes of the rat.
1994
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.
1991
ras oncogenes in human cancer: a review.
1989 Standout
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
2008
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome
1993
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Mutagenicity of Nitroaromatic Compounds
2000
Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome
1991
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations
1995
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
1989
Works of J Lyons being referenced
Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage.
1991
A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177
2014
Cellular oncogenes in human teratocarcinoma cell lines
1990
Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
1990
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
1989
Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation.
1988
RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
1987